Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities-Reference-Cited by-同舟云学术

Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities

Published:2019-01 Issue:1 Volume:14 Page:45-53
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Humphries Matthew P.,McQuaid Stephen,Craig Stephanie G.,Bingham Victoria,Maxwell Perry,Maurya Manisha,McLean Fiona,Sampson James,Higgins Patricia,Greene Christine,James Jacqueline,Salto-Tellez Manuel

Funder

CRUK

Health and Social Care Research and Development Division

Cancer Research UK

Invest Northern Ireland

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Combination cancer immunotherapies tailored to the tumour microenvironment;Smyth;Nat Rev Clin Oncol,2015

2. Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: a systematic review and meta-analysis;Wang;Oncoimmunology,2017

3. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients;Ott;Clin Cancer Res,2013

4. Biomarkers of response to PD-1/PD-L1 inhibition;Maleki Vareki;Crit Rev Oncol Hematol,2017

5. PD-1 blockade in tumors with mismatch-repair deficiency;Le;N Engl J Med,2015

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Deep Learning–Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non–Small Cell Lung Carcinoma: Does it Help Pathologists Score?;Modern Pathology;2024-06

2. Topographic analysis of pancreatic cancer by TMA and digital spatial profiling reveals biological complexity with potential therapeutic implications;Scientific Reports;2024-05-18

3. Clinical Validation of Artificial Intelligence–Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non–Small Cell Lung Cancer;JCO Precision Oncology;2024-05

4. Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation;Archives of Pathology & Laboratory Medicine;2024-04-16

5. Global bibliometric mapping of the research trends in artificial intelligence-based digital pathology for lung cancer over the past two decades;DIGITAL HEALTH;2024-01